Causes of death following small cell lung cancer diagnosis: a population-based analysis

BMC Pulm Med. 2022 Jul 4;22(1):262. doi: 10.1186/s12890-022-02053-4.

Abstract

Purpose: To examine the distribution of causes of death (CODs) in patients with small cell lung cancer (SCLC).

Methods: Patients diagnosed with SCLC were identified from the Surveillance, Epidemiology, and End Results Program database during 2004-2015. Standardized mortality rates (SMRs) were performed for each COD to present changes in risk for a particular COD following SCLC diagnosis.

Results: A total of 44,506 patients diagnosed with SCLC were identified in this study, and 42,476 patients died during the follow-up. Of total deaths, 69.5% occurred within the first years after diagnosis, 26% occurred from 1 to 3 years, and 4.5% individuals survived longer than 3 years. In addition, 88.7% of deaths were caused by SCLC, followed by non-cancer causes (7.1%) and other cancers (4.2%). Moreover, non-cancer CODs increased from 6.3 to 30% over time after 3 years of diagnosis. As for non-cancer CODs, cardiovascular diseases, COPD, and septicemia were the most common in SCLC.

Conclusion: Non-cancer CODs, such as cardiovascular events, COPD and septicemia, contribute to a considerable proportion of deaths among long-term SCLC survivors, supporting the involvement of multidisciplinary care for the follow-up strategy in SCLC.

Keywords: Cause of death; Lung cancer; SCLC; SEER.

MeSH terms

  • Cause of Death
  • Humans
  • Lung Neoplasms*
  • Pulmonary Disease, Chronic Obstructive*
  • Sepsis*
  • Small Cell Lung Carcinoma* / diagnosis